DarioHealth expands its payer network with a new Blue Cross Blue Shield agreement, bolstering recurring revenue growth and reinforcing its position in one of healthcare’s fastest-growing sectors; Dario’s AI-driven digital health platform continues to drive adoption among payers seeking scalable, data-driven solutions
DarioHealth Corp., a leader in the global digital health market, today announced that it has secured a new agreement with a Blue Cross Blue Shield (BCBS) health plan, marking a significant expansion of its presence in the health plan market. The program, rolled out in January 2025, allows members seamless access to Dario’s evidence-based, AI-driven health coaching and monitoring tools.
This agreement will integrate the Dario platform’s comprehensive cardiometabolic digital health solutions, including programs for diabetes, hypertension, and weight management, into the health plan’s suite of member services offered to employers. The agreement is already contributing to the Company’s annual recurring revenue (ARR) in Q1 2025, and as with many of the contracts launched in January of 2025, the relationship with this health plan is expected to expand further throughout the year to cover more of the plan’s population.
HealthTech Insights: MyFitnessPal Launches Weekly Habits: Progress Made Simple, One Week at a Time
This new collaboration with a BCBS-affiliated plan, a trusted leader in healthcare across the U.S., reinforces Dario’s expanding role in delivering digital cardiometabolic care solutions nationwide. With this agreement, Dario now serves nine health plans, spanning both regional and national payers. As the cardiometabolic disease market is projected to surpass $1.2 trillion by 20331, this latest expansion strengthens Dario’s position in one of healthcare’s fastest growing and most financially significant sectors.
HealthTech Insights: Alma Launches First AI-Powered Nutrition Companion App to Make Eating Simple
“We believe that this expansion highlights the increasing demand among payers for scalable, AI-driven digital health solutions that deliver measurable health improvements and cost efficiencies,” said Steven Nelson, Chief Commercial Officer at Dario. ” We believe that securing another Blue Cross Blue Shield health plan further validates our market leadership in cardiometabolic care and reinforces our ability to scale recurring revenue growth. With nine health plans now leveraging our technology, we are rapidly expanding our presence in the multi-billion-dollar payer market and strengthening our trajectory toward profitability and long-term growth.”
HealthTech Insights: Function Health Becomes the Exclusive Biomarker Partner of the NBPA
To participate in our interviews, please write to our HealthTech Media Room at news@intentamplify.com
Source: PR Newswire